Table 1.
In vitro antitumor effects and related mechanisms of action of natural and synthetic oleanane triterpenoids in various breast cancer cells
| Compounds | Effects | Mechanisms | Concentrations | References |
|---|---|---|---|---|
| Oleanolic acid | Displayed weak cytotoxic effects against MCF-7 and MDA-MB- 231 cells | Hsu et al. (2005) | ||
| Exhibited antiproliferative activity against T47D cells | Matysik et al. (2005) | |||
| Exhibited cytotoxic effects against Hs578T and MDA-MB-231 cells | ↑Apoptosis; cholesterol homeostasis; ↓mTORC1; ↓mTORC2 | Chu et al. (2010) | ||
| Elicited modest inhibitory effects on the growth of MCF-7 cells | Mencherini et al. (2011) | |||
| Induced proliferation-inhibiting effects in MCF-7 and MCF-7/ ADR cells | 28–44 μM | Shan et al. (2011) | ||
| Inhibited the survival and proliferation of MCF-7 cells | Cell cycle arrest; ↓ROS; ↓oxidative DNA damage | Allouche et al. (2011) | ||
| Inhibited the survival of MCF-7 cells | ↑p53; ↑p21WAFI/CipI | 6.4 μg/ml | Gu et al. (2012) | |
| Exerted antiproliferative effects in MCF-7 and MDA-MB-231 cells | Cell cycle arrest; ↑apoptosis | 7.0–7.5 μM | Chakravarti et al. (2012) | |
| Remangilones A Remangilones C |
Exhibited cytotoxic effects in MDA-MB-231 and MDA-MB- 435 cells | ↑Apoptosis | 1.6–8.5 μM | Deng et al. (1999) |
| 3β,23,28-Trihydroxy-12- oleanene 23-caffeate; 3β,23,28-Trihydroxy-12- oleanene 3β-caffeate | Showed cytotoxicity against MCF-7 cells | Antioxidant mechanism | 1.8–2.2 μg/ml | Yun et al. (1999) |
| Hederacolchisid A1 | Displayed cytotoxicity against MCF-7 cells | ~10 μM | Barthomeuf et al. (2002) | |
| Maslinic acid | Inhibited the proliferation of MCF-7 cells | 136 μM | He and Liu (2007) | |
| Increased the proliferation of MCF- 7 cells | 12.5–100 μM | Allouche et al. (2011) | ||
| Erythrodiol | Exerted complete inhibition of the proliferation of MCF-7 cells | 12.5–100 μM | Allouche et al. (2011) | |
| β-Amyrin | Exhibited cytotoxicity against in MCF-7 cells | El-Alfy et al. (2011) | ||
| Achyranthoside H methyl ester | Displayed cytotoxic effects against MCF-7 and MDA-MB-453 cells | ↑Sub-G1; PARP cleavage; caspase activation; ↑apoptosis | 2–100 μM | Fukumura et al. (2009) |
| Oleanolic acid derivatives | Exerted antiproliferative effects against MDA-MB-231 cells | 44.8–67.9 μM | Kang et al. (2012) | |
| Exerted growth inhibitory activity against MCF-7 cells | 1.98–35.4 μM | Hao et al. (2013) | ||
| CDDO | Suppressed the proliferation of MCF-7, MDA-MB-231, 21-MT-1, 21-MT-2, 21-NT and 21-PT cells | 3 × 10−2– 1 μM | Suh et al. (1999) | |
| Induced the growth inhibitory effects in MCF-7, MDA-MB-231 and MDA-MB-435 cells | ⊥G1-S; ⊥;G2-M; ↑apoptosis; ↓cyclin D1; ↑p21Waf1/CIP1; ↓Bcl-2 | 0.05–10 μM | Lapillonne et al. (2003) | |
| Retarded the growth of MCF-7 and MDA-MB-435 cells | ↓HER2 phosphorylation; ↓HER2 kinase; ↓caveolin-1 | 3.5–7.5 μM | Konopleva et al. (2006) | |
| CDDO; CDDO-Im | Suppressed the proliferation of MCF-7 cells | 10–30 nM | Place et al. (2003) | |
| CDDO; CDDO-Im | Sensitized T47D and MDA-MB- 468 cells to TRAIL | ↑Apoptosis; ↑DR4; ↑DR5; ↓ FLIPL | Hyer et al. (2005) | |
| CDDO; CDDO-Me | Inhibited the proliferation of MCF-7 cells | 0.06–0.16 μM | Honda et al. (2004) | |
| CDDO-Me | Blocked the proliferation and invasion of 4T1 cells | ⊥G2-M; ↓STAT3; ↓Src; ↓Akt; ↓c-Myc | Ling et al. (2007) | |
| CDDO-Im; CDDO-Me; CDDO-TFEA | Demonstrated cytotoxic activities against W780 and W0069 cells | ↑Apoptosis; ⊥G2-M; ↑ROS; DNA damage | Kim et al. (2011) | |
| CDDO-Me | Exerted antiproliferative effect in W780 cells | ⊥G0-G1; ↓pErbB2 | 0.1–1 μM | Kim et al. (2012) |
| CDDO-Me | Inhibited the proliferation of PyMT cells | ↓CCL2; ↓CXCL2; ↓MMP-9; ↓cyclin D1; ↓EGFR; ↓STAT3 | 0.1–1 μM | Tran et al. (2012) |
| CDDO-Me; CDDO-EA | Reduced the viability of PyMT cells | ↓M-CSF; ↓MMP-9 | 0.1–0.3 μM | Tran et al. (2013) |
| AMR | Exhibited the growth inhibitory effect in MCF-7 cells | 2.5 μg/ml | Rabi et al. (2002) | |
| Exerted cytotoxicity against MCF-7 and MCF-7/TH cells | ↑Apoptosis; ⊥G2-M; ↑total caspase; ↑caspase-8 | 3.8–6.8 μg/ml | Rabi et al. (2003) | |
| Diminished the survival of MCF-7 and MDA-MB-468 cells | ↑Apoptosis; ⊥G2-M; ↑caspase-3/7; ↑p53; ↑Bax; ↓Bcl2 | 1.8–7.0 μM | Rabi et al. (2007) | |
| AMR-Me | Displayed cytotoxic effects against MCF-7 cells | 1.8 μg/ml | Rabi et al. (2002) | |
| Curbed the proliferation of MCF-7 and MCF-7/p53siRNA cells | ↑Apoptosis; ⊥G2-M; ↑caspase-3/7; ↑Bax; ↓Bcl2; ↓cyclin A; ↓cyclin B1; ↑JNK; ↑MAPK | 0.5–0.6 μM | Rabi and Banerjee (2008) | |
| Inhibited the proliferation of MCF-7 and MDA-MB-231 cells | ↑Apoptosis; ↓ER-α; ↓PI3K p85; ↓Akt1; ↓pAkt; ↓NF-κB-DNA binding | 0.15–0.45 μM | Rabi et al. (2013) |